Barclays Keeps Their Buy Rating on Keurig Dr Pepper (KDP)

In a report released on April 26, Lauren Lieberman from Barclays maintained a Buy rating on Keurig Dr Pepper (KDP – Research Report), with a price target of $38.00. The company’s shares closed last Friday at $33.72.

According to TipRanks, Lieberman is a 4-star analyst with an average return of 2.0% and a 53.76% success rate. Lieberman covers the Consumer Defensive sector, focusing on stocks such as Keurig Dr Pepper, PepsiCo, and Church & Dwight.

In addition to Barclays, Keurig Dr Pepper also received a Buy from RBC Capital’s Nik Modi in a report issued on April 26. However, on the same day, TD Cowen maintained a Hold rating on Keurig Dr Pepper (NASDAQ: KDP).

Based on Keurig Dr Pepper’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $3.81 billion and a net profit of $518 million. In comparison, last year the company earned a revenue of $3.62 billion and had a net profit of $180 million

Based on the recent corporate insider activity of 63 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of KDP in relation to earlier this year. Last month, Robert S. Singer, a Director at KDP sold 14,132.00 shares for a total of $413,341.00.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Keurig Dr Pepper (KDP) Company Description:

Massachusetts-based Keurig Dr Pepper, Inc. operates as a non-alcoholic beverage company in the US and internationally. It operates through four segments: Coffee Systems, Packaged Beverages, Beverage Concentrates, and Latin America Beverages.